Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Pediatr Hematol Oncol ; 39(4): 266-271, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-28375940

RESUMEN

Patients treated with vincristine predictably develop peripheral neuropathy. The aim of our study was to investigate the pattern of vincristine-induced neuropathy in children by nerve conduction studies and somatosensory-evoked potentials (SSEPs). We included data from 39 children who received vincristine for various pediatric malignancies, and we performed initial and follow-up (after a minimum of 4 doses of vincristine 1.5 mg/m) conduction studies in 27 patients and SSEPs studies in 34 patients. On follow-up the most prevalent symptoms were paresthesias (44%) and constipation (22%), and the most common neurological sign was impaired myotatic reflexes (89%). Performing nerve conduction studies we found that significant reductions were measured for distal amplitudes, distal latencies were prolonged, and conduction velocities were relatively preserved. The most pronounced differences in amplitudes and distal latencies were measured in the peroneal nerves. Changes of SSEPs studies were subtle. Vincristine-induced neuropathy presents with primary axonal involvement and is more pronounced on motor neurons. We found a trend between higher age and higher dose and the degree of neuropathy in our group of patients.


Asunto(s)
Electrofisiología/métodos , Potenciales Evocados Somatosensoriales , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Vincristina/efectos adversos , Adolescente , Niño , Preescolar , Femenino , Humanos , Masculino , Neoplasias/complicaciones , Neoplasias/tratamiento farmacológico , Conducción Nerviosa/efectos de los fármacos , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Nervio Peroneo/fisiopatología , Adulto Joven
2.
Pediatr Gastroenterol Hepatol Nutr ; 26(1): 70-77, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36816438

RESUMEN

Hepatic hemangiomas (HH) - classified into congenital hepatic hemangiomas (CHH) or infantile hepatic hemangiomas (IHH) - are benign vascular tumors that are mainly asymptomatic, but may cause clinical problems that require treatment. While focal, multifocal, and diffuse IHH are responsive to propranolol treatment, CHH is mainly focal and thought to be resistant to treatment with propranolol. The clinical and imaging distinctions between CHH and IHH in cases of focal lesions can be challenging, while histopathological distinction is mostly lacking in the clinical setting. We report 4 neonatal symptomatic cases of focal HH treated with propranolol, with partial or complete resolution of the tumor, and the positive hemodynamic effect of propranolol in one case. We believe that although clear differentiation cannot be achieved between CHH and IHH without histopathological examination in cases of focal HH in neonates, propranolol treatment should be attempted in symptomatic cases since its benefits outweigh the possible small risk of side effects of propranolol.

5.
Clin Neurol Neurosurg ; 112(7): 597-601, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20371148

RESUMEN

OBJECTIVES: Spasticity, cognitive impairment, depression and fatigue significantly reduce the quality of life in multiple sclerosis (MS) patients. To find out whether nonpharmalogical treatment approaches can reduce these symptoms we investigated effects of sports climbing (SC) and yoga on spasticity, cognitive impairment, mood change and fatigue in MS patients. Sports climbing (SC) and yoga are aerobic physical activities comprised a series of stretching techniques, implementation of which demands body control and planning of complex movements. MATERIALS AND METHODS: 20 subjects with relapsing-remitting or progressive MS, 26-50 years of age, with EDSS2 were enrolled in a randomized prospective study. The participants were randomly divided into SC and yoga group. We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods. RESULTS: There were no significant improvements in spasticity after SC and yoga. In the SC group we found a 25% reduction (p=0.046) in EDSSpyr. There were no differences in executive function after the completion of both programs. There was a 17% increase in selective attention performance after yoga (p=0.005). SC reduced fatigue for 32.5% (p=0.015), while yoga had no effect. We found no significant impact of SC and yoga on mood. CONCLUSIONS: Yoga and SC might improve some of the MS symptoms and should be considered in the future as possible complementary treatments.


Asunto(s)
Afecto/fisiología , Cognición/fisiología , Montañismo/fisiología , Esclerosis Múltiple/psicología , Esclerosis Múltiple/rehabilitación , Fatiga Muscular/fisiología , Espasticidad Muscular/etiología , Espasticidad Muscular/rehabilitación , Aptitud Física , Yoga , Adulto , Depresión/etiología , Depresión/psicología , Ejercicio Físico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/complicaciones , Pruebas Neuropsicológicas , Proyectos Piloto , Escalas de Valoración Psiquiátrica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA